Breaking News Instant updates and real-time market news.

BABY

Natus Medical

$39.70

-0.45 (-1.12%)

06:03
10/19/16
10/19
06:03
10/19/16
06:03

Natus Medical sees FY16 adjusted EPS $1.63-$1.66, consensus $1.55

Sees FY16 revenue $381.2M-$383.2M, consensus $377.83M.

  • 19

    Oct

  • 29

    Nov

BABY Natus Medical
$39.70

-0.45 (-1.12%)

09/13/16
RAJA
09/13/16
UPGRADE
Target $46
RAJA
Outperform
Natus Medical upgraded to Outperform on earnings power at Raymond James
As previously reported, Raymond James analyst Jayson Bedford upgraded Natus Medical to Outperform from Market Perform with a $46 price target. Bedford recently met with management and came away more confident that capital deployment will be larger than expected, potentially increasing earnings meaningfully and acting as a catalyst for shares. He believes Natus will likely add businesses that are adjacent to their core Neurology and Newborn businesses, and would not be surprised to see it carve out a non-core business from a larger entity.
09/26/16
ROTH
09/26/16
NO CHANGE
Target $47
ROTH
Buy
Otometrics acquisition positive for Natus Medical, says Roth Capital
Roth Capital analyst Chris Lewis notes that Natus Medical announced the acquisition of Otometrics for $145M and an expected Q3 revenue shortfall. While the analyst is disappointed with the shortfall, he believes the main driver is transient in nature and should pass by the beginning of 2017. Further, Lewis sees the Otometrics acquisition as a "meaningful positive" for Natus Medical as it significantly expands the company and should allow it to reach $500M in annual revenues in 2017. He reiterates a Buy rating and $47 price target on the shares.
10/04/16
BNCH
10/04/16
INITIATION
Target $55
BNCH
Buy
Natus Medical initiated with a Buy at Benchmark
Benchmark analyst Raymond Myers started Natus Medical with a Buy rating and $55 price target.
10/18/16
ROTH
10/18/16
NO CHANGE
Target $47
ROTH
Buy
Roth Capital remains a buyer of Natus Medical ahead of results
Roth Capital analyst Chris Lewis notes that Natus Medical is expected to release full quarterly earnings on Wednesday, but has already announced a Q3 revenue shortfall. While the analyst is disappointed with the miss, he believes the likely earning accretion from Otometrics acquisition should drive stock upside over the medium to long term. He reiterates a Buy rating and $47 price target on the shares.

TODAY'S FREE FLY STORIES

ORCL

Oracle

$46.29

-0.25 (-0.54%)

07:17
06/20/18
06/20
07:17
06/20/18
07:17
Downgrade
Oracle rating change  »

Oracle downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$197.46

-0.84 (-0.42%)

07:16
06/20/18
06/20
07:16
06/20/18
07:16
Recommendations
Facebook analyst commentary  »

Facebook Messenger…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FDX

FedEx

$258.35

-5.295 (-2.01%)

07:16
06/20/18
06/20
07:16
06/20/18
07:16
Recommendations
FedEx analyst commentary  »

FedEx results 'good…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 21

    Sep

AAL

American Airlines

$41.51

-0.93 (-2.19%)

07:15
06/20/18
06/20
07:15
06/20/18
07:15
Periodicals
American Airlines prepares for management-level layoffs, buyouts, CNBC reports »

American Airlines told…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

MERC

Mercer

$16.15

-0.25 (-1.52%)

07:15
06/20/18
06/20
07:15
06/20/18
07:15
Upgrade
Mercer rating change  »

Mercer upgraded to Buy on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NGD

New Gold

$2.09

(0.00%)

07:15
06/20/18
06/20
07:15
06/20/18
07:15
Downgrade
New Gold rating change  »

New Gold downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SBUX

Starbucks

$57.43

0.22 (0.38%)

07:14
06/20/18
06/20
07:14
06/20/18
07:14
Recommendations
Starbucks analyst commentary  »

UBS keeps Buy rating, $66…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

NKE

Nike

$74.27

-1.33 (-1.76%)

07:11
06/20/18
06/20
07:11
06/20/18
07:11
Recommendations
Nike analyst commentary  »

Nike price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 28

    Jun

MTN

Vail Resorts

$280.81

-4.21 (-1.48%)

07:11
06/20/18
06/20
07:11
06/20/18
07:11
Initiation
Vail Resorts initiated  »

Vail Resorts initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

POOL

Pool Corp.

$154.54

0.52 (0.34%)

07:10
06/20/18
06/20
07:10
06/20/18
07:10
Initiation
Pool Corp. initiated  »

Pool Corp. initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PLNT

Planet Fitness

$45.11

-0.5 (-1.10%)

07:09
06/20/18
06/20
07:09
06/20/18
07:09
Initiation
Planet Fitness initiated  »

Planet Fitness initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NLS

Nautilus

$16.40

-0.1 (-0.61%)

07:09
06/20/18
06/20
07:09
06/20/18
07:09
Initiation
Nautilus initiated  »

Nautilus initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SRPT

Sarepta

$143.92

38.44 (36.44%)

07:09
06/20/18
06/20
07:09
06/20/18
07:09
Recommendations
Sarepta analyst commentary  »

Sarepta price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

GLOB

Globant

$56.99

-0.01 (-0.02%)

07:09
06/20/18
06/20
07:09
06/20/18
07:09
Syndicate
Globant announces commencement of 5.8M share secondary offering »

WPP plc (WPP) and Globant…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

FOXF

Fox Factory

$44.10

0.2 (0.46%)

07:09
06/20/18
06/20
07:09
06/20/18
07:09
Initiation
Fox Factory initiated  »

Fox Factory initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HSGX

Histogenics

$2.74

-0.13 (-4.53%)

07:06
06/20/18
06/20
07:06
06/20/18
07:06
Recommendations
Histogenics analyst commentary  »

Histogenics Phase 3 study…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BDRBF

Bombardier

$0.00

(0.00%)

, DAL

Delta Air Lines

$53.78

-1.025 (-1.87%)

07:06
06/20/18
06/20
07:06
06/20/18
07:06
Hot Stocks
Delta Air Lines orders 20 Bombardier CRJ900 valued at approx. $961M »

Bombardier Commercial…

BDRBF

Bombardier

$0.00

(0.00%)

DAL

Delta Air Lines

$53.78

-1.025 (-1.87%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 29

    Jun

APEN

Apollo Endosurgery

$5.60

-0.3 (-5.08%)

07:06
06/20/18
06/20
07:06
06/20/18
07:06
Syndicate
Apollo Endosurgery 3.747M share Spot Secondary priced at $5.50 »

Craig-Hallum acted as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AIG

AIG

$55.50

-0.065 (-0.12%)

07:05
06/20/18
06/20
07:05
06/20/18
07:05
Hot Stocks
AIG acquires Ellipse from Munich Re »

AIG and Munich Re…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DUK

Duke Energy

$75.67

1.28 (1.72%)

07:05
06/20/18
06/20
07:05
06/20/18
07:05
Upgrade
Duke Energy rating change  »

Duke Energy upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WGO

Winnebago

$40.40

-0.35 (-0.86%)

07:04
06/20/18
06/20
07:04
06/20/18
07:04
Earnings
Winnebago reports Q3 EPS $1.02, consensus 91c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

07:04
06/20/18
06/20
07:04
06/20/18
07:04
General news
MBA Mortgage Applications Composite Index data reported »

Week of 6/15 MBA Mortgage…

SPX

S&P 500

$0.00

(0.00%)

07:04
06/20/18
06/20
07:04
06/20/18
07:04
Technical Analysis
S&P 500: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMRX

Amneal Pharmaceuticals

$18.83

-0.69 (-3.53%)

07:03
06/20/18
06/20
07:03
06/20/18
07:03
Hot Stocks
Amneal announces patent litigation settlement agreement with Actavis »

Amneal Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PGLC

Pershing Gold

$1.86

-0.04 (-2.11%)

07:03
06/20/18
06/20
07:03
06/20/18
07:03
Hot Stocks
Pershing Gold files Plan of Operations for Relief Canyon Mine expansion »

Pershing Gold submitted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.